GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
June 3 (Reuters) - Shares of GSK (GSK.L), opens new tab dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused ...
PARIS, Jan 4 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Wednesday its dispute with Germany's Boehringer Ingelheim over potential liability for cancer claims in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback